drugset / Trial / NCT03333395

Nebulized Heparin and Salbutamol in Mechanically Ventilated Patients With AECOPD

NCT03333395

Phase 4 Completed 60 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindTreatment

Summary

This randomised study was designed to assess the efficacy of nebulised heparin and salbutamol in improving lung function in mechanically ventilated patients with AECOPD.

Timeline

Start
2017-02-01
Primary completion
2017-09-30
Completion
2017-09-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Heparin Other / unclassified 25000 iu Other
Comparator Salbutamol Unknown 2.5 mg Other

Indications

No indication recorded.